The EDCTP Forum provides an international platform for the presentation and discussion of cutting-edge research addressing the burden of poverty-related infectious diseases in sub-Saharan Africa and the capacity development and networking activities that support this goal.
The main programme (virtual and live from Maputo) runs from 18-20 October 2021, featuring plenary presentations by keynote speakers, scientific sessions of oral and poster presentations, sponsored symposia.
The theme of the Tenth EDCTP Forum is Equity in research for health. The programme is structured in four tracks:
A: Advancing biomedical interventions towards improved and equitable health
B: Equity challenges in cross-cutting issues
C: Addressing inequities in research
D: Capacity strengthening, South-South collaboration, enhancing the research environment
Follow MMV and partners participation at the Forum
19 October (13:00 - 14:00 Mozambique Time)
Main post-approval and real-life studies conducted and ongoing in parallel with the launch and scale-up of Pyramax in Africa (sponsored by Medicines for Malaria Venture)
20 October (13:00 – 14:00 Mozambique Time)
Advances in Intermittent Preventive Treatment of malaria in infants (IPTi) for improved and equitable health for children under 2 in sub-Saharan Africa (sponsored by Barcelona Institute of Global Health)
Advocacy challenges and opportunities for stepping up support for poverty-related and neglected disease R&D after COVID-19 (sponsored by Deutsche Stiftung Weltbevölkerung)
- MiMBa “Gender equity in research and development – accelerating appropriate antimalarial options during pregnancy and breastfeeding”
- A Phase II study to evaluate a novel treatment and develop an innovative clinical endpoint for efficient drug development in severe malaria (KARISMA – KAE609’s Role in Severe Malaria)
- Optimizing the impact of Seasonal Malaria Chemoprevention: improving delivery and building capacity for evaluation: an update on project progress
The SINDOFO project: A Phase II multicenter clinical trial of a Ferroquine + ZY19489 (MMV253) short regimen for the treatment of malaria
Visit the Tenth EDCTP Forum website for more information.